CKD Bio Corp. - ROE
063160.KS
Price:
$13550
Market Cap:
$74.33B
CKD Bio Corp., a South Korean company founded in 1941 and headquartered in Seoul, specializes in the production and distribution of pharmaceutical active ingredients (APIs). Their manufacturing processes leverage diverse technologies, including fermentation, chemical synthesis, and biotechnology. The company's extensive portfolio of APIs targets a broad spectrum of therapeutic applications, encompassing antibiotics, beta-lactamase inhibitors, immunosuppressants, oncology treatments, anti-obesity medications, dry eye remedies, antiviral and antituberculosis agents, antihyperlipidemics, and probiotics. Beyond its core manufacturing, CKD Bio Corp. also provides contract research, development, a...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-01-04
Stock Exchange
KSC
Ticker
063160.KS
PE Ratio
[-68.97]
ROE
[-8.59%]
Current Ratio
[1.06]
Dividend Yield
[0%]
Enterprise Value
[221.76B]
Dividend History
The ROE as of September 2026 (TTM) for CKD Bio Corp. (063160.KS) is -8.59%
According to CKD Bio Corp.’s latest financial reports and current stock price. The company's current ROE is -8.59%. This represents a change of 293.72% compared to the average of -2.18% of the last 4 quarters.
CKD Bio Corp. (063160.KS) Historical ROE (quarterly & annually)
How has 063160.KS ROE performed in the past?
The mean historical ROE of CKD Bio Corp. over the last ten years is -0.12%. The current -8.59% ROE has changed 6.83% with respect to the historical average. Over the past ten years (40 quarters), 063160.KS's ROE was at its highest in in the June 2024 quarter at 3.39%. The ROE was at its lowest in in the December 2023 quarter at -6.61%.
Average
-0.12%
Median
4.53%
Minimum
-19.66%
Maximum
7.74%
CKD Bio Corp. (063160.KS) ROE by Quarter and Year
Discovering the peaks and valleys of CKD Bio Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 177.50%
Maximum Annual ROE = 7.74%
Minimum Annual Increase = -210.71%
Minimum Annual ROE = -19.66%
| Year | ROE | Change |
|---|---|---|
| 2025 | -2.27% | -134.23% |
| 2024 | 6.64% | -133.77% |
| 2023 | -19.66% | 74.01% |
| 2022 | -11.30% | 177.50% |
| 2021 | -4.07% | -210.71% |
| 2020 | 3.68% | -52.47% |
| 2019 | 7.74% | 43.65% |
| 2018 | 5.39% | -4.52% |
| 2017 | 5.64% | -19.15% |
| 2016 | 6.98% | 33.64% |
CKD Bio Corp. (063160.KS) Average ROE
How has 063160.KS ROE performed in the past?
The current ROE of CKD Bio Corp. (063160.KS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.10%
5-year avg
-6.13%
10-year avg
-0.12%
CKD Bio Corp. (063160.KS) ROE vs. Peers
How is 063160.KS’s ROE compared to its peers?
CKD Bio Corp.’s ROE is greater than Aprogen Biologics Inc. (-36.87%), less than Jeil Pharma Holdings Inc (2.66%), less than Ildong Holdings Co., Ltd. (13.43%), greater than SAMSUNG PHARM. Co., Ltd. (-109.02%), greater than Enzychem Lifesciences Corporation (-12.31%), less than Hyundai Pharmaceutical Co., Ltd. (4.19%), less than CG Invites Co., Ltd. (0.47%), less than DongKook Life Science (0%), less than Kyongbo Pharmaceutical Co., Ltd (3.42%), less than KUKJE PHARMA Co., Ltd. (5.12%),
| Company | ROE | Market cap |
|---|---|---|
| -36.87% | $24.20B | |
| 2.66% | $116.05B | |
| 13.43% | $71.78B | |
| -109.02% | $124.71B | |
| -12.31% | $83.79B | |
| 4.19% | $193.93B | |
| 0.47% | $71.67B | |
| 0% | $72.60B | |
| 3.42% | $132.20B | |
| 5.12% | $71.84B |
Build a custom stock screener for CKD Bio Corp. (063160.KS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CKD Bio Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
CKD Bio Corp. (063160.KS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like CKD Bio Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is CKD Bio Corp.'s ROE?
How is the ROE calculated for CKD Bio Corp. (063160.KS)?
What is the highest ROE for CKD Bio Corp. (063160.KS)?
What is the 3-year average ROE for CKD Bio Corp. (063160.KS)?
What is the 5-year average ROE for CKD Bio Corp. (063160.KS)?
How does the current ROE for CKD Bio Corp. (063160.KS) compare to its historical average?